Chain-breaking antioxidant activity of reduced forms of
















































The oxidative stress caused by reactive oxygen species 
(ROS) is assumed to significantly contribute to aging 
and numerous age-related pathologies. Mitochondria are 
known as a place,  where the most intensive ROS produc- 
 
 
                                                       Research paper 















































































quinones  (QH2)  have  quantitatively  been  measured  for  the  first  time.  To  this  end,  the  chain  peroxidation  of  methyl



















tion can occur. In the recent years, mitochondria-
targeted antioxidants has been developed [1-4]. 
Research was the series of papers published by our 
group in 1969-1970, where mitochondria-addressed 
penetrating synthetic cations were described and the 
idea to use these cations as “electric locomotives” 
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put forward [5, 6]. In the late nineties, Murphy and 
coworkers initiated the practical realization of this idea 
[1, 7-9]. They synthesized and tested several mitochon-
dria-targeted antioxidants conjugated to the lipophilic 
alkyltriphenylphosphonium cations. The ubiquinone 
moiety linked to triphenylphosphonium cation by C10 
aliphatic chain, MitoQ (Figure 1), seemed to be the most 
promising [1, 4, 9].  
 
In 2005, an attempt was undertaken in our group to 
replace the ubiquinone moiety in MitoQ by plasto-
quinone. As a result, a series of mitochondria-targeted 
antioxidants named SkQ has been synthesized [2, 10]. 
There were two main reasons for this modification. (1) 
Plastoquinone playing in chloroplasts the same role of an 







































operates under conditions of oxidative stress (elevated 
oxygen concentration and an intensive ROS production). 
(2) It was reported [11-13] that the reactivity of the 
“tailless” plastoquinol analogs to the peroxyl radicals was 
indeed higher than that of natural ubiquinols. The 
advantage of mitochondria-targeted quinones of SkQ 
type over MitoQ was recently demonstrated by using 
several biological models. In particular, it was found that 
very low doses of SkQ1 (nmol/kg per day) prolong life of 
podospora, ceriodaphnia, drosophila and mice. In mice, 
SkQ1 doubled median lifespan arrested development of 
such traits of the senescence process as involution of 
thymus and decline of other immunity mechanisms; 
osteo-porosis; disappearance of regular estrous cycles in 
females, cataract, retinopathies, balding, catinies, 
hypothermia, chromosome aberrations, peroxidation of 








































   































Until recently, the reactivity of the mitochondria-
targeted antioxidants has, in fact, not been 
quantitatively determined. This was done in the present 
paper. The structure of the compounds studied is 
presented in Figure 1. The chain-breaking antioxidant 
activity was characterized by the rate constant for 
reaction of QH2 with the lipid peroxyl radical, LO2
•, 
formed from ML or cardiolipin: 
   LO2
•  + QH2  ⎯→  LOOH  + QH
• k 1             (1) 
which competes with the reaction of chain propagation 
of lipid peroxidation 
   LO2
•  + LH (+O2)  ⎯→  LOOH  + LO2




Figure 2 shows that SkQ1 is almost completely reduced 
to SkQ1H2 by NaBH4. For SkQ1, the m/z value was 
found to be 537.08, which corresponds to the 
theoretically calculated one. As expected, the m/z value 
for SkQ1H2 proved to be 539.1, i.e. m/z increased by two 
units as compared with that for SkQ1. Similar results 
were also obtained for the reduction of other 




































The non-inhibited oxidation of ML in Triton micelles is 
a chain process, which rate, R0, was found to be 
proportional to [ML] and square root of [AAPH] (not 
shown) as it was reported in our preceding papers 
[21,22]. Such relationships are also inherent in the lipid 
peroxidation in other aqueous microheterogeneous 
systems [23-25]. They correspond to the “classic” 
kinetic scheme with bimolecular chain termination [26, 
27]. 
 
   AAPH  +  LH  +  (O2)  ⎯→ LO2
•  + products  RIN    (0)  
   LO2
•  +  LH  +  ⎯→ LOOH  + L
•            k2     (2) 
   L
•  +  O2  ⎯→  LO2
•               k3     (3) 
   LO2
• + LO2
•  ⎯→  products            2k4    (4) 
 
All the tested QH2 displayed a pronounced chain-
breaking antioxidant activity as this is exemplified by 
Figure  3  for SkQ1H2. When SkQ1H2 was added, the 
rate of oxidation, R, dramatically decreased. As 
SkQ1H2 was progressively consumed due to reaction 
(1), R increased with time and eventually reaches the 
level of non-inhibited oxidation. As a result, the 
pronounced induction period was observed (Figure 3A).  
 
   




























Quantitatively similar [O2] traces were observed with 
all the other tested QH2 as well as with α-tocopherol 
and its synthetic analog 6-hydroxy-2,2,5,7,8-
pentamethylchromane (HPMC). As for C12TPP, a 
compound that has no hydroquinone moiety (Figure 1), 
it did not display any inhibiting activity (not shown). 
Meanwhile, oxidized form of SkQ1 showed a weak 
inhibition of ML oxidation, but only during a very short 
period of time (Figure 4). Most likely, the inhibition is 
caused in this case by a minor contamination of 
SkQ1H2 to SkQ1. A similar effect was also observed 
with other mitochondria-targeted Q. This suggests that 
mitochondria-targeted quinones by themselves do not 
act as a chain-breaking antioxidant.  
 
The reduced forms of mitochondria-targeted quinones 
studied in this work are p-hydroquinones. Acting as 
chain-breaking antioxidants during the chain 
peroxidation of styrene p-hydroquinones, “tailless” 
analogs of mitochondria-targeted antioxidants show a 
very high inhibiting activity [11], sometimes 




−1 [26]). For instance, k1 for Me3BQH2 was found 
to be as much as 2.2 × 10
6 M
−1s
−1 (Table 1). The 
behavior of p-hydroquinones in such a system does not 
differ from that of monophenolic antioxidants [26, 27]. 

































peroxidation of ML in aqueous micelles [12, 28]. The 
matter is that p-hydroxy-substituted phenoxyl radicals 
QH
• formed in reaction (1) having, as a rule, pK less 
than 5 [29] undergo fast deprotonation at neutral pH: 
 
     QH
•   ⎯→   Q
•−   +   H
+                                        (5) 
 
with the formation of semiquinone anion, Q
•−, which 




     Q
•−   +  O2   ⎯→   Q   +   O2
•−                             (6) 
 
In turn, O2
•− may react with oxidation substrate and 
QH2, most likely in its protonated form, HO2
•. Both 
reactions result in a decrease in the inhibitory activity of 
QH2 [28]. SOD removes O2
•−and thus arrests the 
mentioned undesirable reactions with the participation 
of O2
•− (HO2
•). This was a reason why SOD was always 
added to our system.  
 
The [O2] traces recorded during the induction period of 
the inhibited oxidation of ML were used to determine 
k1. On the base of a reductive kinetic scheme, which 
includes reactions (0), (1), (2), and (4), the following 
equation can be deduced [11,12] 
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where [LH] is the concentration of the oxidation 
substrate (in our case ML). Figure 3B depicts the 
original [O2] trace (Figure 3A) in the axes of Eq. (7). It 
is seen that the plot of F vs. time is a straight line as 
predicted by Eq. (7). The kinetic behavior of all the 
other QH2 studied proved to be was similar. The value 
of k1/k2 can be calculated from the slope of this straight 
line by using Eq. 7. It should be noted that this way of 
calculation of k1/k2 does not require the knowledge in 
RIN and the starting concentration of QH2. The values of 
k1/k2 are listed in Table 1. The absolute values of k1 









































The k1 values are also listed in Table 1.  
constant t















With two QH2, SkQ1H2 and MitoQH2, similar expe-
riments were conducted by using the same testing 
system, but with substituting ML by cardiolipin, the most 
oxidizable phospholipid component in mitochondria 
membranes [32, 33]. As seen from Figure 5, both [O2] 
traces during the induction period of the inhibited 
oxidation and the plots of F vs. time are very similar to 
those for ML. The value of k1/k2 was calculated from the 
slope of the plot B (Figure 5) by using Eq. (7) assuming 
that each molecule of cardiolipin contains four fatty acid 
residue with 87 % linoleate in the cardiolipin sample 
used in this work (see www.avantilipids.com). These data 
are also presented in Table 1. Unfortunately, the absolute 
values of k1 could not be calculated, as k2 for the 































a k 1/k2 






3670 ± 280 (7) 
1980 ± 170 (3)
c 
2.2 ± 0.2 
nd 
SkQ3H2  2720 ± 210 (4)  1.6 ± 0.1 
SkQ5H2  2670 ± 180 (5)  1.6 ± 0.1 
MitoQH2  970 ± 55 (6) 
520 ± 37 (3)
c 
0.58 ± 0.03   
nd 
DMQH2  1260 ± 85 (4)  0.76 ± 0.5 









1.3 ± 0.1 
23
d  
Me4BQH2  5020 ± 380 (3)  3.0 ± 0.2 
Ubiquinol-0  700 ± 45 (3)  0.42 ± 0.03 
4.4
d  
α-tocopherol 1170  ± 70 (4)  0.70 ± 0.04 
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In this paper, the reactivity of the reduced forms of the 
mitochondria-targeted quinones as chain-breaking anti-
oxidants has systematically been studied. As may be 
seen from Table 1, the k1 value for SkQ1H2, SkQ3H2 
and SkQ5H2 are significantly higher than that for 
MitoQH2. This is in line with the data for simple 
“tailless” analogs of SkQ1H2 and MitoQH2, namely 
Me3BQH2, Me4BQH2 and Ubiquinol-0. The same 
tendency was earlier observed when effects of “tailless” 
analogues on the chain oxidation of styrene in bulk [11] 
and ML peroxidation in SDS micelles were studied 
[12]. Possible reasons why methyl-substituted p-
hydroquinones are better antioxidants than methoxy-
substituted p-hydroquinones were described elsewhere 
[11, 26]. In brief, the effect under consideration is, the 
most probably, stereoelectronic by its nature. The 
matter is that o-methoxy group forms H-bond with 
oxygen belonging to the adjacent OH group. This 
causes the decrease in overlap between p-type orbital of 
oxygen atom of OH-group and the aromatic π-electron 
cloud (the increase of the dihedral angle between the 
aromatic ring and O – H bond). The latter results in 
strengthening O – H bond as compared with that in o-
methyl substituted QH2, where such an intramolecular 





























Among mitochondria-targeted QH2 studied in this work, 
SkQ1H2 showed the highest reactivity towards the lipid 
peroxyl radicals (Table 1). This observation is in line 
with data obtained in our group by using several 
biological models [2, 10, 14]. However, we recognize 
that the highest value of k1 for SkQ1H2 is likely not the 
only reason for the outstanding biological activity of 
SkQ1. It should be taken into account that k1 given in 
Table 1 are effective values and cannot be directly 
attributed to the elementary reaction (1). The genuine 
values of k1 can be determined during the chain 
oxidation in non-polar media, for instance in styrene 
[11, 34, 35]. When going to the oxidation of fatty acid 
(ester) in bulk [12, 36] and further to the oxidation in 
aqueous micelles and liposomes [12, 26, 37], the 
experimentally determined k1 values significantly 
decrease, nearly by one order of magnitude (see data for 
ubiquinol-0, Table 1). A reason for such a reduction of 
k1 was repeatedly discussed. The mentioned decrease in 
k1 is not specific of QH2. A similar effect has earlier 
been also reported for the oxidation inhibited by 
monophenolics [25, 26, 37, 38]. The formation of H-
bonds between the OH-group of phenolics and the 
carboxy-group of ML has been suggested as the main 
reason for the k1 decrease when going from the 
oxidation of non-polar hydrocarbon to that of fatty acid 
(ester) [36]. Recently, hydrogen bonding between 
phenols and fatty acid esters was directly observed by 
using the NMR technique [39]. Most likely, this is also 
true for QH2 studied in this work. The further decrease 
in k1 when going from ML oxidation in bulk to that in 
aqueous micelles may be explained by the additional 
formation of H-bonds between QH2 and water 
molecules as this was earlier suggested for 
monophenolics [23, 37, 38].  
 
A general specific feature of reduced forms of the 
studied mitochondria-targeted quinoles is that their 
reactivity is actually very close to that of their “tailless” 
analogs (Table 1). This is in contrast to the couple “α-
tocopherol having the long aliphatic chain its “tailless” 
analog HPMC. The k1 value for α-tocopherol is nearly 
one order of magnitude lower than that for HPMC 
(Table 1). This effect was reported to be even more 
pronounced in the SDS micelles [23, 37, 38]. The 
essential feature of our testing system and related 
microheterogeneous systems is that the concentration of 
the antioxidants tested is much lower than that of the 
oxidation substrate (in our case ML). While every 
micelle (microreactor) contains several molecules of 
ML, only a few micelles contain an antioxidant. Under 
these conditions, a fast LO2
• reduction by an antioxidant 
is possible only if an antioxidant is capable of fast 
transferring from one microreactor to another, the 
characteristic time of this transfer being shorter than the  
Figure 4. The effect of addition of 10 μM SkQ1 on the kinetics
of oxygen consumption during the oxidation of 20 mM ML in 50
mM  micellar  solution  of  50  mM  Triton  X‐100  in  50mM
phosphate  buffer,  pH  7.40,  37  °C,  initiated  by  3  mM  AAPH.
Arrow shows the moment when SkQ1 was added. 
   


























time of the occurrence of a single kinetic chain. The 
antioxidants with a rather long aliphatic residue like α-
tocopherol commonly do not meet such a requirement 
[37]. The fact that the values of k1 for the mitochondria-
targeted quinols actually do not differ from that of their 
“tailless” analogs (Table 1) means that all of them are 
capable of the fast transfer from one microreactor to 
another. This is in line with a high reported ability of 
SkQ and MitoQ to easily penetrate through biological 
membranes [14]. 
 
MATERIALS AND METHODS 
 
Methyl linoleate and Triton X-100 were purchased from 
Sigma, heart bovine cardiolipin disodium salt was 
received from Avanti PolarLipids. The water-soluble 
initiator 2,2’-azobis(2-amidinopropan) dihydrochloride 
(AAPH) was obtained from Polysciences. NaH2PO4 and 
Na2HPO4 of the highest quality used to prepare buffer 
solutions were purchased from Merck. The 
mitochondria-targeted quinones, SkQ1, SkQ3, SkQ5, 
MitoQ, DMQ as well as C12TPP (see Figure 1) were 
synthesized in the Mitoengineering Centre of Moscow 
State University [2]. Trimethylhydroquinone (Me3BQH2) 
was purchased from Aldrich; 2,3-dimethoxy-5-methyl-
benzoqyuinone (ubiquinone-0) was from Sigma; 
tetramethylbenzoquinone (Me4BQ) was from EGA 
































The reduced forms of the mitochondria-targeted 
quinones (QH2) were produced by the reduction of 
corresponding quinones by NaBH4 in the mixture of 50 
mM NaH2PO4 (pH 5.0) with ethanol. This process was 
under control of UPLC-MS-MS (see below). Reduced 
forms of ubiquinone-0 and tetramethylhydroquinone 
(Me4BQH2) were produced by reduction of the 
quinones by Zn powder [21]. The buffer solution (pH 
7.40 ± 0.02) was prepared by mixing 50 mM solutions 
of NaH2PO4 and Na2HPO4. In turn, the solutions of the 
individual sodium phosphates were prepared with 
doubly distilled water and were purged from traces of 
transition metals by Chelex-100 resin (Bio-Rad). 
 
HPLC-diode array detection-electrospray ionization 
tandem mass spectrometry analysis (UPLC-MS-MS) 
was performed using an ACQUITY system (Waters, 
Milford, MA, USA). Chromatography was carried out 
using an ACQUITY BEH C18 column (2.1 x 50 mm, 
1.7 μm) eluted with a gradient of 40-60% acetonitrile (4 
min) and 20 mM acetic acid (pH 3.0) delivered at a flow 
rate of 0.5 mL per min. UV-monitoring was performed 
at 280 mm. An injection volume of 11.2 μL (full loop) 
was used in all cases. A Quattro triple-quadrupole mass 
spectrometer (Micromass-Waters) fitted with a Z-Spray 
ion interface was used for analyses. Ionization was 
achieved using electrospray in a positive ionization 
mode. The following conditions were found to be 
optimal for the analysis of SkQ1: capillary voltage, 3.0 
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gas (nitrogen) heated to 450°C and delivered at a flow 
rate of 800 L h
−1; cone voltage, 55 V; cone Gas Flow 
rate, 50 L h
−1. MassLynx 4.0 software (Waters) was 
used for processing. 
 
The standard testing system was composed of 50 mM 
buffer, pH 7.4, 50 mM Triton X-100, 2-4 mM AAPH, 
8-20 mM ML and 20 unit mL
−1 S O D .  I n  s o m e  
experiments, ML was replaced by cardiolipin. The 
kinetics of oxygen consumption accompanied ML 
(cardiolipin) oxidation were studied with a 
computerized 5300 Biological Oxygen Monitor (Yellow 
Springs Instruments Co., USA) with a Clark electrode 
as a sensor. The rate of oxidation was measured as a 
slope of [O2] traces. Experiments were conducted at 
37.0  ± 0.1 °С. ML was added to preliminarily 
thermostated micellar solution of Triton X-100 and 
AAPH in buffer. Monitoring was started 3-5 min after 
ML addition and the rate of non-inhibited oxidation (R0) 
was measured. The tested compounds were then added 
to a reaction chamber under steady monitoring as a 
stock solution by using a Hamilton micro-syringe. In 
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